UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000010160 |
|---|---|
| Receipt number | R000011896 |
| Scientific Title | Phase II trial as new chemotherapy regimen for bevacizumab (Bev) in combination with XELOX in unresectable colorectal cancer. |
| Date of disclosure of the study information | 2013/04/01 |
| Last modified on | 2019/01/18 17:08:29 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/03/04 22:02:36 | ||
| 2 | Update | 2014/09/04 20:42:37 | TEL Last name of contact person Last name of contact person Address TEL |
|
| 3 | Update | 2014/09/04 20:43:55 | Recruitment status |
|
| 4 | Update | 2015/09/04 19:15:28 | Recruitment status |
|
| 5 | Update | 2019/01/18 17:08:29 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded Results |
